Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy
Public ClinicalTrials.gov record NCT00957918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Parallel Group, Placebo Controlled Safety, Tolerability and Efficacy Study of NP002 in Subjects With Idiopathic Parkinson's Disease With Dyskinesias Due to Levodopa Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is designed to answer the question: will nicotine at doses that do not cause serious side effects, show feasibility in treatment of levodopa-induced dyskinesia in patients with Parkinson's disease?
Study identification
- NCT ID
- NCT00957918
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 83 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Aug 31, 2010
- Completion
- Aug 31, 2010
- Last update posted
- Oct 4, 2011
2009 – 2010
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurology Clinics at St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| Keck/USC School of Medicine -Department of Neurology | Los Angelis | California | 90033 | — |
| Pacific Neuroscience Medical Group | Oxnard | California | 93030 | — |
| Colorado Neurological Institute | Englewood | Colorado | 80113 | — |
| Parkinson's Disease & Movement Disorders Ctr of Boca Raton | Boca Raton | Florida | 33486 | — |
| Collier Neurologic Specialists, LLC | Naples | Florida | 34102 | — |
| Strurers Parkinson's Center | Golden Valley | Minnesota | 55427 | — |
| David L. Kreitzman, M.D., P.C. | Commack | New York | 11725 | — |
| 108-14 72nd Ave, Second floor | Forest Hills | New York | 11375 | — |
| Duke University Medical Center, Department of Neurology | Durham | North Carolina | 27705 | — |
| The Movement Disordedr Clinic of Oklahoma | Tusla | Oklahoma | 74137 | — |
| Parkinson's Disease and Movement Center, Penn Comprehensive Neuroscience Center | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00957918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 4, 2011 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00957918 live on ClinicalTrials.gov.